Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Dev Neuropsychol ; 48(5): 215-247, 2023 07 04.
Article in English | MEDLINE | ID: mdl-37341559

ABSTRACT

There is conflicting evidence whether single-suture craniosynostosis (SSC), is linked to adversities of cognitive development. To assess the evidence for a link between SSC and cognition, a systematic literature search was conducted and eligible studies assessed for inclusion by two independent readers. Forty-eight studies met inclusion criteria. Small to medium but persistent effects on both general and some specific cognitive functions across age bands were found in higher quality studies for SSC overall. There was limited evidence for effects related to surgical correction. Methodologies varied substantially and there was a lack of longitudinal studies using broad assessment batteries.


Subject(s)
Craniosynostoses , Humans , Craniosynostoses/complications , Craniosynostoses/surgery , Craniosynostoses/psychology , Cognition , Longitudinal Studies , Sutures
2.
J Craniomaxillofac Surg ; 45(6): 981-989, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28389105

ABSTRACT

Posterior calvarial vault osteodistraction (PCVO) has become increasingly popular in the correction of craniosynostosis. When compared to cranioplasty, PCVO offers a shorter, less invasive operation, greater intracranial volume advancement and a lower rate of relapse. In general, distraction protocols are based primarily on clinical observations rather than systematic research. Faster distraction protocols may reduce complications. However, distraction protocols producing higher forces can increase complications. Thus, we need to understand these forces in order to improve distraction protocols and devices. We developed a force measurement method that can be used on PCVO devices. Here, we present preliminary data about the forces developed during PCVO. We measured the forces in four bicoronal craniosynostosis patients during PCVO. We observed a linear-like trend between the force increase and the distraction distance within distraction sessions. We also observed a step-wise force increase between distraction sessions and found that the distraction force relaxed rapidly shortly after the distraction session. The mean maximum pre-distraction force for one distracter was 20.4 N, while the mean maximum end-distraction force for one distracter was 57.6 N. Our data suggests that current treatment protocols might be re-evaluated favouring shorter distraction distances and more frequent distraction sessions.


Subject(s)
Craniosynostoses/surgery , Osteogenesis, Distraction/methods , Craniosynostoses/diagnostic imaging , Female , Humans , Imaging, Three-Dimensional , Infant , Radiographic Image Interpretation, Computer-Assisted , Stress, Mechanical , Tomography, X-Ray Computed , Torque , Treatment Outcome
3.
Am J Transplant ; 11(2): 386-93, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21214855

ABSTRACT

Composite facial allotransplantation is emerging as a treatment option for severe facial disfigurements. The technical feasibility of facial transplantation has been demonstrated, and the initial clinical outcomes have been encouraging. We report an excellent functional and anatomical restoration 1 year after face transplantation. A 59-year-old male with severe disfigurement from electrical burn injury was treated with a facial allograft composed of bone and soft tissues to restore midfacial form and function. An initial potent antirejection treatment was tapered to minimal dose of immunosuppression. There were no surgical complications. The patient demonstrated facial redness during the initial postoperative months. One acute rejection episode was reversed with a brief methylprednisolone bolus treatment. Pathological analysis and the donor's medical history suggested that rosacea transferred from the donor caused the erythema, successfully treated with topical metronidazol. Significant restoration of nasal breathing, speech, feeding, sensation and animation was achieved. The patient was highly satisfied with the esthetic result, and regained much of his capacity for normal social life. Composite facial allotransplantation, along with minimal and well-tolerated immunosuppression, was successfully utilized to restore facial form and function in a patient with severe disfigurement of the midface.


Subject(s)
Burns, Electric/surgery , Facial Injuries/surgery , Facial Transplantation/methods , Burns, Electric/pathology , Facial Injuries/pathology , Facial Transplantation/adverse effects , Facial Transplantation/pathology , Facial Transplantation/physiology , Graft Rejection/etiology , Humans , Male , Middle Aged , Rosacea/etiology , Rosacea/pathology
4.
J Cell Biochem ; 110(5): 1226-33, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20544797

ABSTRACT

Connective tissue growth factor (CTGF/CCN2) is a matricellular protein induced by transforming growth factor (TGF)-beta and intimately involved with tissue repair and overexpressed in various fibrotic conditions. We previously showed that keratinocytes in vitro downregulate TGF-beta-induced expression of CTGF in fibroblasts by an interleukin (IL)-1 alpha-dependent mechanism. Here, we investigated further the mechanisms of this downregulation by both IL-1alpha and beta. Human dermal fibroblasts and NIH 3T3 cells were treated with IL-1alpha or beta in presence or absence of TGF-beta1. IL-1 suppressed basal and TGF-beta-induced CTGF mRNA and protein expression. IL-1alpha and beta inhibited TGF-beta-stimulated CTGF promoter activity, and the activity of a synthetic minimal promoter containing Smad 3-binding CAGA elements. Furthermore, IL-1alpha and beta inhibited TGF-beta-stimulated Smad 3 phosphorylation, possibly linked to an observed increase in Smad 7 mRNA expression. In addition, RNA interference suggested that TGF-beta activated kinase1 (TAK1) is necessary for IL-1 inhibition of TGF-beta-stimulated CTGF expression. These results add to the understanding of how the expression of CTGF in human dermal fibroblasts is regulated, which in turn may have implications for the pathogenesis of fibrotic conditions involving the skin.


Subject(s)
Connective Tissue Growth Factor/metabolism , Fibroblasts/drug effects , Interleukin-1alpha/pharmacology , Interleukin-1beta/pharmacology , Animals , Blotting, Western , Connective Tissue Growth Factor/genetics , Dermis/cytology , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Expression Regulation/drug effects , Humans , MAP Kinase Kinase Kinases/genetics , MAP Kinase Kinase Kinases/metabolism , Mice , NIH 3T3 Cells , Phosphorylation/drug effects , Promoter Regions, Genetic/genetics , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction , Smad3 Protein/metabolism , Smad7 Protein/genetics , Smad7 Protein/metabolism , Transforming Growth Factor beta/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...